Companies: 10,795·Total market cap: $144.5T
Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc.

INSPNYSEHealthcare● Active
$41.71
+$0.52(+1.26%)
Market Cap$1.2B
P/E Ratio
52W High$147.03
52W Low$38.91

Inspire Medical Systems, Inc. (INSP) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

insp · stock forecast · 27 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 27 Wall Street analysts in the past 3 months

SellBuy

Hold

27 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
11
Hold
16
Sell
0
Strong Sell
0
Total: 27 · Buy rate: 40.7%

12-Month Price Target

High

$70.00

Consensus

$57.36

+39.3% upside

Low

$39.00

Median: $55 · Last Close: $41.19

The Inspire Medical Systems, Inc. (INSP) analyst consensus is Hold, based on ratings from 27 Wall Street analysts over the past 3 months. The average 12-month INSP price target is $57.36, representing +39.3% upside from the current price of $41.19.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $57 (39.3%)

Consensus Target

$57.36

39.3% upside

High Target

$70

69.9%

Low Target

$39

-5.3%

Current Price

$41.19

as of today

Based on analyst price targets, the INSP stock price prediction for the next 12 months ranges from $39 to $70. The consensus INSP price forecast of $57.36 implies 39.3% upside from the current price of $41.19.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$40.032.81%

1-day model range: $39.67–$40.39. Peak: $40.39 (-2.81%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$26-36.0%
2028$21-48.6%
2029$19-54.2%
2030$18-57.0%
2031-58.4%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

7%7%86%
1Buy
1Neutral
12Sell
RSI (14)54.1Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · INSP · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$41.05BUY
MA 10$41.77SELL
MA 20$42.36SELL
MA 50$49.20SELL
MA 100$58.54SELL
MA 200$75.48SELL
Current $INSP · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$41.37SELL
EMA 10$41.83SELL
EMA 20$43.47SELL
EMA 50$49.20SELL
EMA 100$59.13SELL
EMA 200$77.40SELL
Current $INSP · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Oppenheimer2026-05-07
Maintains
PerformPerform
Wells Fargo2026-05-05
Maintains
Equal WeightEqual Weight
JP Morgan2026-05-05
Maintains
NeutralNeutral
Stifel2026-05-05
Maintains
BuyBuy
Baird2026-05-05
Maintains
NeutralNeutral
RBC Capital2026-05-05
Maintains
Sector PerformSector Perform
Mizuho2026-05-05
Maintains
OutperformOutperform
Piper Sandler2026-05-05
Downgrade ↓
OverweightNeutral
Truist Securities2026-05-05
Maintains
HoldHold
Evercore ISI Group2026-05-05
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on Inspire Medical Systems, Inc. (INSP) stock. Of the recent 186 rating actions, 10 were upgrades and 13 were downgrades. 27 analysts currently cover INSP.

Analyst Recommendation Trends

Buy ratings532
Hold ratings37↑ +4
Sell ratings00

INSP analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 5 to 3 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$843M

↓ 11.9% YoY

Revenue Next Year

$880M

↑ 4.3% YoY

EPS This Year

$0.90

EPS Next Year

$1.28

↑ 42.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast INSP EPS of $0.90 for the current fiscal year, based on estimates from 9 analysts. The INSP revenue forecast is $843M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The INSP stock forecast is supported by two independent data sources: analyst consensus ratings from 27 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus INSP price target is $57.36 (+39.3% upside), with an analyst consensus of Hold.

The INSP short-term stock prediction for tomorrow is $40.03 (-2.81%). The INSP stock price prediction for 2027 estimates an average of $26. The INSP stock prediction for 2030 projects a range of $16–$19.

Inspire Medical Systems, Inc. trades on NYSE under the ticker INSP. The INSP stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 41% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

INSP forecast · 8 questions

According to 27 Wall Street analysts, the average 12-month INSP price target is $57.36, with a high forecast of $70.00 and a low of $39.00. The median price target is shown in the chart above when available. This implies +39.3% potential upside from the current price of $41.19.

INSP price targetWhat is INSP price targetINSP analyst price targetINSP 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.